Long-term neurodevelopmental outcome in conservatively treated congenital hyperinsulinism

European Journal of Endocrinology

Volumn 157, Issue 4, 2007, Pages 491-497

  Mazor Aronovitch, K ^a   Gillis, D ^b   Lobel, D ^c   Hirsch, H J ^d   Pinhas Hamiel, O ^a   Modan Moses, D ^a   Glaser, B ^b   Landau, H ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c Pediatric Hematology Oncology   (Israel)

^d SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZOXIDE; OCTREOTIDE;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CEREBRAL PALSY; CHILDHOOD; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DIABETES MELLITUS; FATHER; GENE MUTATION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INTERVIEW; JEW; LEARNING DISORDER; MOTOR DYSFUNCTION; MUSCLE HYPOTONIA; NERVOUS SYSTEM DEVELOPMENT; OUTCOME ASSESSMENT; PANCREAS RESECTION; PARENT; PERINATAL PERIOD; PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PRIORITY JOURNAL; QUESTIONNAIRE; REMISSION; SCHOOL CHILD; SEIZURE; SIBLING; SPEECH DISORDER; TELEPHONE;

ADOLESCENT; ADULT; ATP-BINDING CASSETTE TRANSPORTERS; BRAIN; CHILD; CHILD DEVELOPMENT; DEVELOPMENTAL DISABILITIES; DIABETES MELLITUS; FOLLOW-UP STUDIES; HUMANS; MUTATION; NERVOUS SYSTEM; PANCREATECTOMY; PERSISTENT HYPERINSULINEMIA HYPOGLYCEMIA OF INFANCY; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RECEPTORS, DRUG; TIME FACTORS; TREATMENT OUTCOME;

EID: 35548935196     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-07-0445     Document Type: Article

References (26)

1. Aynsley-Green A, Hussain K, Hall J, Saudubray JM, Nihoul-Fekete C & Lonlay-Debeney P. Practical management of hyperinsulinism in infancy. Archives of Disease in Childhood. Fetaland Neonatal Edition 2000 82 F98-F107.
2. Otonkoski T, Ammala C, Huopio H, Cote GJ, Chapman J & Cosgrove K. A point mutation inactivating the sulfonylurea receptor causes the severe form of persistent hyperinsulinemic hypoglycemia of infancy in Finland. Diabetes 1999 48 408-415.
3. Mathew PM, Young JM, Abu-Osba YK, Mulhern BD, Hammoudi S & Hamdan JA. Persistent neonatal hyperinsulinism. Clinical Pediatrics 1988 27 148-151.
4. Nestorowicz; A, Wilson BA, Schoor KP, Inoue H, Glaser B & Landau H. Mutations in the sulonylurea receptor gene are associated with familial hyperinsulinism in Ashkenazi Jews. Human Molecular Genetics 1996 5 1813-1822.
5. de Lonlay P, Fournet JC, Rahier J, Gross-Morand MS, Poggi-Travert F & Foussier V. Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy. Journal of Clinical Investigation 1997 100 802-807.
6. Ryan F, Devaney D, Joyce C, Nestorowicz A, Permutt MA & Glaser B. Hyperinsulinism: molecular aetiology of focal disease. Archives of Disease in Childhood 1998 79 445-447.
7. Henwood MJ, Kelly A, MacMullen C, Bhatia P, Ganguly A & Thornton PS. Genotype-phenotype correlations in children with congenital hyperinsulinism due to recessive mutations of the adenosine triphosphate-sensitive potassium channel genes. Journal of Clinical Endocrinology and Metabolism 2005 90 789-794.
8. Huopio H, Jaaskelainen J, Komulainen J, Miettinen R, Karkkainen P & Laakso M. Acute insulin response tests for the differential diagnosis of congenital hyperinsulinism. Journal of Clinical Endocrinology and Metabolism 2002 87 4502-4507.
9. Ferry RJ Jr, Kelly A, Grimberg A, Koo-McCoy S, Shapiro MJ & Fellows KE. Calcium-stimulated insulin secretion in diffuse and focal forms of congenital hyperinsulinism. Journal of Pediatrics 2000 137 239-246.
10. Grimberg A, Ferry RJ Jr, Kelly A, Koo-McCoy S, Polonsky K & Glaser B. Dysregulation of insulin secretion in children with congenital hyperinsulinism due to sulfonylurea receptor mutations. Diabetes 2001 50 322-328.
11. Leibowitz G, Glaser B, Higazi AA, Salameh M, Cerasi E & Landau H. Hyperinsulinemic hypoglycemia of infancy (nesidioblastosis) in clinical remission: high incidence of diabetes mellitus and persistent beta-cell dysfunction at long-term follow-up. Journal of Clinical Endocrinology and Metabolism 1995 80 386-392.
12. Glaser B, Hirsch HJ & Landau H. Persistent hyperinsulinemic hypoglycemia of infancy: long-term octreotide treatment without pancreatectomy, Journal of Pediatrics 1993 123 644-650.
13. Glaser B, Landau H & Permutt MA. Neonatal Hyperinsulinism. Trends in Endocrinology and Metabolism 1999 10 55-61.
14. Glaser B & Landaw H. Long-term treatment with the somatostatin analogue SMS 201-995: alternative to pancreatectomy in persistent hyperinsulinaemic hypoglycaemia of infancy. Digestion 1990 45 27-35.
15. Reimann F, Huopio, H, Dabrowski M, Proks P, Gribble FM & Laakso M. Characterisation of new KATP-channel mutations associated with congenital hyperinsulinism in the Finnish population. Diabetologia 2003 46 241-249.
16. Huopio H, Otonkoski T, Vauhkonen I, Reimann F, Ashcroft FM & Laakso M. A new subtype of autosomal dominant diabetes attributable to a mutation in the gene for sulfonylurea receptor 1. Lancet 2003 361 301-307.
17. Gillis D, Landau H, Zangen DH & Glaser B. Glucose intolerance in patients with persistent hyperinsulinemic hypoglycemia of infancy. Abstract 2086, 82nd annual meeting of the endocrine society, June 2000.
18. Menni F, de Lonlay P, Sevin C, Touati G, Peigne C & Barbier V. Neurologic outcomes of 90 neonates and infants with persistent hyperinsulinemic hypoglycemia. Pediatrics 2001 107 476-479.
19. Meissner T, Wendel U, Burgard P, Schaetzle S & Mayatepek E. Longterm follow-up of 114 patients with congenital hyperinsulinism. European Journal of Endocrinology 2003 149 43-51.
20. Gross-Tsur V, Shalev RS, Wertman-Elad R, Landau H & Amir N. Neurobehavioral profile of children with persistent hyperinsulinemic hypoglycemia of infancy. Developmental Neuropsychology 1994 10 153-163.
21. Steinkrauss L, Lipman TH, Hendell CD, Gerdes M, Thornton PS & Stanley CA. Effects of hypoglycemia on developmental outcome in children with congenital hyperinsulinism. Journal of Pediatric Nursing 2005 20 109-118.
22. Giurgea I, Ribeiro MJ, Boddaert N, Touati G, Robert JJ & Saudubray JM. Congenital hyperinsulinism in newborn and infant. Archives of Pediatrics 2005 12 1628-1635.
23. Ribeiro MJ, de Lonlay F, Delzescaux T, Boddaert N, Jaubert F & Bourgeois S. Characterization of hyperinsulinism in infancy assessed with PET and 18F-fluoro-L-DOPA. Journal of Nuclear Medicine 2005 46 560-566.
24. Otonkoski T, Nanto-Salonen K, Seppanen M, Veijola R, Huopio H & Hussain K. Noninvasive diagnosis of focal hyperinsulinism of infancy with [18F]-DOPA positron emission tomography. Diabetes 2006 55 13-18.
25. Mohnike K, Blankenstein O, Christesen HT, De Lonlay J, Hussain K & Koopmans KP. Proposal for a standardized protocol for 18F-DOPA-PET (PET/ CT) in congenital hyperinsulinism. Hormone Research 2006 66 40-42.
26. Lindley KJ, Knafelz D, St Louis D, Dunne MJ, Aynsley-Green A & Milla PJ. Surface electrogastrographic evidence of foregut dysmotility in persistent hyperinsulinaemic hypoglycaemia of infancy (PHHI). Journal of Physiology 1997 499 108.